| Name | Title | Contact Details |
|---|
NextPlay Technologies, Inc. (Nasdaq: NXTP) is a technology solutions company offering gaming, in-game advertising, crypto-banking, connected TV and travel booking services to consumers and corporations within a growing worldwide digital ecosystem. NextPlay`s engaging products and services utilize innovative AdTech, Artificial Intelligence and Fintech solutions to leverage the strengths and channels of our existing and acquired technologies. For more information about NextPlay Technologies
Xalles Holdings Inc. is a holdings company that focuses on direct investments in disruptive fintech companies. The company actively seeks acquisition targets with solid management teams and business models, large total attainable markets (TAM), and lucrative exit opportunities to invest and accelerate growth in. Recently, the company has placed emphasis on leveraging blockchain technologies to provide industry-leading financial reconciliation and auditing solutions, which will allow for the capture of recurring revenue streams over time.
Cerberus Technologies is a White Rock, BC-based company in the Computers and Electronics sector.
Using artificial intelligence for augmenting regulatory research and ESG issues management. RegASK™`s digital platform routinely monitors, anticipates and reports updates or changes to relevant regulations with instant alerts. Our platform also allows us to zero-in on applicable regulations to identify and analyze any gaps in the compliance of a product. RegASK™ was created by the founders of SPRIM, after more than 17 years of consulting on globalization projects and researching regulatory guidelines for healthcare companies across six of the seven continents. RegASK™ is backed by a team of regulatory experts with a global perspective and years of navigating some of the most complicated regulatory hurdles in markets big and small.
Cota is a technology platform that enables providers, payers, and life science companies involved in diagnosing and treating complex diseases to optimize the care of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.